TELA Bio, Inc.
General ticker "TELA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $66.1M (TTM average)
TELA Bio, Inc. follows the US Stock Market performance with the rate: 2.3%.
Estimated limits based on current volatility of 3.1%: low 1.11$, high 1.18$
Factors to consider:
- Total employees count: 227 (+31.2%) as of 2023
- Top business risk factors: Liquidity and credit risks, Market acceptance, Supply chain disruptions, Regulatory and compliance, Economic downturns and volatility
- Current price 33.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.71$, 4.84$]
- 2025-12-31 to 2026-12-31 estimated range: [1.81$, 4.94$]
Financial Metrics affecting the TELA estimates:
- Positive: with PPE of -2.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -50.40 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 32.87 <= 41.86
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -2.81 <= -0.75
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term TELA quotes
Long-term TELA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $41.42MM | $58.45MM | $69.30MM |
| Operating Expenses | $80.42MM | $102.53MM | $103.42MM |
| Operating Income | $-39.01MM | $-44.08MM | $-34.12MM |
| Non-Operating Income | $-5.29MM | $-2.59MM | $-3.87MM |
| Interest Expense | $4.05MM | $5.22MM | $5.29MM |
| R&D Expense | $8.94MM | $9.62MM | $8.81MM |
| Income(Loss) | $-44.30MM | $-46.66MM | $-37.98MM |
| Taxes | $0.00MM | $0.00MM | $-0.14MM |
| Profit(Loss)* | $-44.30MM | $-46.66MM | $-37.84MM |
| Stockholders Equity | $14.30MM | $18.88MM | $28.46MM |
| Inventory | $11.79MM | $13.16MM | $12.78MM |
| Assets | $67.86MM | $78.05MM | $86.57MM |
| Operating Cash Flow | $-40.75MM | $-40.86MM | $-41.59MM |
| Capital expenditure | $1.87MM | $0.61MM | $0.99MM |
| Investing Cash Flow | $-1.87MM | $-0.60MM | $4.45MM |
| Financing Cash Flow | $40.85MM | $46.27MM | $43.06MM |
| Earnings Per Share** | $-2.72 | $-2.04 | $-1.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.